Helminthic therapy and low-dose naltrexone (LDN)
Helminthic therapy and Low-dose naltrexone are fully compatible[edit | edit source]
Helminths and LDN are a good combination for most users[edit | edit source]
One treatment may be better than the other for a few users[edit | edit source]
LDN does not suit everyone[edit | edit source]
A clinical scientist involved in helminthic therapy has commented:
And LDN can cause side effects, especially when dosing guidelines (see below) are not followed.
Changes to sleep patterns (when taken at night)
Mild stomach upset that usually resolves quickly
Mild self-limiting headache that goes away after a few days
Dosing is critical with LDN[edit | edit source]
It is recommended that LDN should be introduced at a maximum of 1 mg per day. This may be taken at nighttime (after 9pm) - or in the morning. The timing appears to make no difference to the response.
After taking 1 mg daily for 7 days, the dose can be increased by 1 mg every 7 days until 4 mg is reached. It can then be increased to 4.5 mg.
In some cases, especially with M.E. and CFS, the dosing regimen should start at 0.5 mg daily, and increase by 0.5 mg every week until 4.5 mg is reached. This reduces the risk of side effects.
The following advice on dosing to optimise LDN’s healing potential was posted to the Helminthic Therapy Support group in response to a member who was not maintaining his early success with LDN.
LDN works in such a way as to trick the body into healing itself. Initially when taken, LDN blocks a certain amount of your opioid receptor's (depending on dose) and then after 4 hours, half the dose is eliminated from the body (naltrexone has a half life of 4 hours - it takes 4 hours for HALF of the dose taken to be eliminated). The effects of this blockade is that the body responds by increasing its production of endogenous endorphins and enkephalins. It is the increased production of the met-enkaphalin called Opioid Growth Factor (OGF) and its receptor (OGFr) that does the healing - this is the 'rebound effect' - where the elevated OGF interact with the more-sensitive and more-plentiful OGF receptors acting together as a powerful endogenous cell growth regulator called the OGF/OGFr axis. In the 'rebound effect' the OGF/OGFr axis is modulated causing it to slow down proliferating cells in the disease process. This anti-proliferative action will help inhibit inflammation, slow down the disease process and promote homeostasis. [19]
LDN dosing may need to be re-optimised when combined with helminthic therapy[edit | edit source]
One subject who found LDN to be "super helpful" as a partner to HT also discovered that even very low doses of TSO (up to 300 ova every 2 weeks) reduced the amount of LDN that she needed, such that she began to get sicker again due what had become, for her while taking the TSO, an excessive amount of LDN. So, at a fortnightly dose of 300 TSO, she settled on half the dose of LDN that she had been taking previous to starting the TSO.
See also[edit | edit source]
Here are several discussion threads on HT and LDN from the Helminthic Therapy Support group.
- Has anyone tried low dose naltrexone before trying helminthic therapy? How do the two compare in terms of effectiveness?
- Anyone here also try Low Dose Naltrexone (LDN) yet? for any autoimmune issue, but especially for Crohns/IBD?
- Has anyone seen any significant results (with LDN)? At what dosage? Also are there any negative side effects at such low doses?
- How many people here tried LDN before HT?